BSE filing, NSE: RLFL. Summary written from the filing by ALFA Finder's alert engine.
Raama Finance Ltd: key numbers
- Share price
- ₹9.98
- Market cap
- ₹81.00 Cr
- Revenue (annual)
- ₹12.06 Cr
- Net profit (annual)
- ₹3.24 Cr
- P/E (TTM)
- 10.9×Sector 19.7×
- Promoter holding
- 49.06%-5.87% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Raama Finance Ltd
All →Raama Finance Management Change
Raama Finance Limited informed the exchange about the resignation of its Statutory Auditor, M/s. Goyal Nagpal and Co., effective from October 06, 2026.
Raama Finance Annual General Meeting
Raama Finance held its 33rd Annual General Meeting on September 30, 2026. Shareholders discussed and approved the company's financial statements and the re-appointment of a director.
Raama Finance Investor Presentation: Key Takeaways
Raama Finance reported strong Q1FY27 results, transitioning to a fully digital AI-driven lending model targeting the salaried workforce. Revenue reached ₹21.31 Cr, exceeding the entirety of FY26.
Raama Finance Capital Structure Change
Raama Finance approved allotting 97 lakh equity shares (₹4.66 Cr) upon warrant conversion and 4,610 NCDs (₹4.61 Cr). The Board also reorganized management.
- Value
- ₹9.27 Cr
Raama Finance Management Change
Raama Finance Limited has appointed Mr. Jitendar Prasad as its new Chief Executive Officer, effective September 22, 2026.
Raama Finance Debt & Borrowing: ₹5 Cr
Raama Finance approved issuance of ₹5 Crore NCDs (18-month, 20% PA) via private placement. The board also appointed Mr. Jitendar Prasad as CEO effective September 22, 2026.
- Value
- ₹5.00 Cr
- Execution
- 18 months
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.